RVL Pharmaceuticals plc Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
RVL Pharmaceuticals plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2022.
  • RVL Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$23.9M, a 97.3% decline year-over-year.
  • RVL Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$68.3M, a 20.8% decline year-over-year.
  • RVL Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2022 was -$51.7M, a 20.4% increase from 2021.
  • RVL Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2021 was -$64.9M, a 18.4% increase from 2020.
  • RVL Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2020 was -$79.6M, a 70.6% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$51.7M +$13.2M +20.4% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-20
2021 -$64.9M +$14.7M +18.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$79.6M +$191M +70.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$271M -$161M -147% Jan 1, 2019 Dec 31, 2019 8-K 2021-09-08
2018 -$110M -$68.4M -166% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 -$41.3M Jan 1, 2017 Dec 31, 2017 8-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.